⋮
0
0
武田的EXKIVITY™ (mobocertinib)成为美国FDA首次核准的专为EGFR外显子20插入+ NSCLC患者设计的口服治疗药物
Showing live article 1952 of 3352 in channel 19681208
Article Details:
Author:
Language: Japanese
Channel Number: 19681208
Article Number: 1952
Date: September 16, 2021, 11:36 pm
URL: http://www.qlifepro.com/press/20210918-00-84283/ma-takeda-pharma-16/
GUID: http://www.qlifepro.com/press/?p=84283
←
$
X
X
NSFW?
Claim
0
X
Mark channel Not-Safe-For-Work?
cancel
confirm
NSFW Votes:
(
0
votes)
X
Are you the publisher?
Claim
or
contact us about
this channel.
X
0
X
RSSing.com
Search
Sharing:
Title:
URL:
Copy Share URL